ASSESSMENT OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY . Int. Res. J. Pharm. 2019;10(1):160-164. Accessed July 30, 2026. https://irjponline.org/index.php/irjp/article/view/244